India Upholds Prevnar 13 Patent In Big Win For Pfizer

India has awarded Pfizer a patent for its blockbuster pneumonia vaccine Prevnar13, handing the pharmaceutical giant a big victory in a case which has been closely watched as a key test of the country’s patentability criteria.

Indian moneybox
SIGNS OF CHANGE ON IPR FRONT IN INDIA?

India’s patent office granted Pfizer Inc. a patent for its best-selling pneumonia vaccine PCV13 vaccine, marketed as Prevnar 13, barring other companies from making cheaper generic versions of the injection and allowing the company exclusive rights to sell it in the country of 1.3bn people until 2026.

Humanitarian group Médecines Sans Frontières, which had opposed Pfizer’s patent bid, said it feared the decision indicated a watering down...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip